Valiant Laboratories Segment Revenue Breakdown
₹120.94-1.84%close, 9 Oct 2026
- Market cap
- ₹657 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹87.08 – ₹163.27
Consolidated revenue breakdown by business segment for Valiant Laboratories.
Valiant Laboratories business segment revenue mix
Breakdown of consolidated revenue by business segment and division.
| Business Segment | Revenue (₹ cr) | Share % |
|---|---|---|
| Core Operations & Products | 263 | 68.5% |
| Retail & Enterprise Services | 98.53 | 21.2% |
| Digital & Technology Solutions | 52.55 | 10.3% |
Core Operations & Products68.5%
Retail & Enterprise Services21.2%
Digital & Technology Solutions10.3%
Source: Company annual report and quarterly segment disclosures. How this data is compiled.
Same Data For Peers
- Ventive Hospitality Limited business segment revenue
- Vaishali Pharma Limited business segment revenue
- Venus Remedies Limited business segment revenue
- Unichem Laboratories Limited business segment revenue
- Vijaya Diagnostic Centre Limited business segment revenue
- TTK Healthcare Limited business segment revenue
Trade Valiant Laboratories With ATS
Track VALIANTLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.